Chemistry:3-Chloro-PCP
From HandWiki
3-Chloro-PCP (3'-Cl-PCP) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has comparable potency to phencyclidine but with a slightly different effects profile,[1] being somewhat more potent as an NMDA antagonist but around the same potency as a dopamine reuptake inhibitor.[2] It was first identified in Slovenia in December 2020.[3]
Legal status
Hungary
3Cl-PCP was made illegal in Hungary in April 2021.[4]
Japan
3Cl-PCP was regulated as Shitei Yakubutsu in Japan from May 2026. Its manufacture, importation, sale, possession, and use were prohibited in principle.[5]
See also
- 3-F-PCP
- 3-Me-PCP
- 3-MeO-PCP
- 4-Keto-PCP
References
- ↑ "Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents". J Pharmacol Exp Ther 390 (1): 14–28. Jun 2024. doi:10.1124/jpet.123.001942. PMID 38272671.
- ↑ "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry 11. 2020. doi:10.3389/fpsyt.2020.632405. PMID 33633599.
- ↑ "Analytical Report. 3Cl-PCP (C17H24ClN). 1-[1-(3-chlorophenyl)cyclohexylpiperidine."]. National Forensic Laboratory. Slovenia. https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/3Cl-PCP-ID-2201-20_report.pdf.
- ↑ "Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU". Minister for Human Capacities. 30 December 2014. https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN.
- ↑ 厚生労働省 (May 17, 2026). "医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律第二条第十五項に規定する指定薬物及び同法第七十六条の四に規定する医療等の用途を定める省令（平成十九年厚生労働省令第十四号）". https://laws.e-gov.go.jp/law/419M60000100014?occasion_date=20260314#:~:text=%E7%99%BE%E5%8D%81%E5%9B%9B%E3%80%80%E4%B8%80%E2%80%95%EF%BC%BB%E4%B8%80%E2%80%95%EF%BC%88%E4%B8%89%E2%80%95%E3%82%AF%E3%83%AD%E3%83%AD%E3%83%95%E3%82%A7%E3%83%8B%E3%83%AB%EF%BC%89%E3%82%B7%E3%82%AF%E3%83%AD%E3%83%98%E3%82%AD%E3%82%B7%E3%83%AB%EF%BC%BD%E3%83%94%E3%83%9A%E3%83%AA%E3%82%B8%E3%83%B3%E5%8F%8A%E3%81%B3%E3%81%9D%E3%81%AE%E5%A1%A9%E9%A1%9E.
 |  |
